SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LELSHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TABATABAEI P.; SAIDATI A.; KHOTAII G.; MAMISHI S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ACTA MEDICA IRANICA Year:2004 | Volume:42 | Issue:1 Page(s): 61-64

Download Full-Text

View:

231

Download:

Cites:

Information Journal Paper

Title

SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LELSHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE

Author(s)

TABATABAEI P. | SAIDATI A. | KHOTAII G. | MAMISHI S. | Issue Writer Certificate

Keywords

VISCERAL LEISHMANIASIS

MEGLUMINE ANTIMONATE

AMPHOTERICIN B

Abstract

VISCERAL LEISHMANIASIS (VL) is usually treated with pentavalent antimonial drugs given alone or in combination with other drugs. The efficacy of these treatments is diminishing, however, and development of alternative treatments has been recommended. we studied 13 patients with leishmaniasis who were unresponsive to MEGLUMINE ANTIMONATE, at a dose of 20 mg/kg body weight/per day given for 30 days. These patients were treated with daily regimen of AMPHOTERICIN B, starting with an escalating dose of 0.1mg/kg body per day until a day dose of 1.5 mg/kg was reached for a period of 4 weeks. All 13 patients using the treatment regimen were cured; no patient relapse in one year of follow-up Treatment of VISCERAL LEISHMANIASIS (kala-azar) with the daily regimen of AMPHOTERICIN B at a dose of 1.5 mg/kg body weight was effective.

Cites

No record.

References

Cite

APA: Copy

TABATABAEI, P., SAIDATI, A., KHOTAII, G., & MAMISHI, S.. (2004). SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LELSHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE. ACTA MEDICA IRANICA, 42(1), 61-64. SID. https://sid.ir/paper/277493/en

Vancouver: Copy

TABATABAEI P., SAIDATI A., KHOTAII G., MAMISHI S.. SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LELSHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE. ACTA MEDICA IRANICA[Internet]. 2004;42(1):61-64. Available from: https://sid.ir/paper/277493/en

IEEE: Copy

P. TABATABAEI, A. SAIDATI, G. KHOTAII, and S. MAMISHI, “SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LELSHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE,” ACTA MEDICA IRANICA, vol. 42, no. 1, pp. 61–64, 2004, [Online]. Available: https://sid.ir/paper/277493/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops